The present study was conducted to determine the effects of dietary metabolisable energy (ME) density and L-carnitine supplementation on the performance, carcass traits and blood parameters of broiler chickens. The experiment was designed with three levels of dietary energy (low, medium and high) and two levels of L-carnitine (0 and 100 mg/kg diet) in a 3x2 factorial arrangement. L-carnitine supplementation did not significantly affect body weight gain (BWG), feed intake (FI) and feed conversion ratio (FCR). However, FCR and BWG showed a significant improvement as dietary energy density increased. No significant interactions were observed between energy density and L-carnitine supplementation in the performance and carcass parameters studied in the study. Carcass yield and proportion of carcass sections were not affected significantly by any of the treatments. Chemical composition of the leg (thigh and drumstick) and breast muscle was not significantly influenced by dietary energy or carnitine, with the exception of the dry matter (DM) content of breast muscle. A low ME diet caused a significant increase in the DM content of chicken breast muscle. Furthermore, blood parameters did not show any differences between treatments. However, aspartate aminotransferase (AST) activity in blood was elevated in chickens fed a high ME diet compared to those on a low ME diet. The results of the investigation showed that Lcarnitine supplementation produced no significant improvement in broiler performance and meat quality. Higher levels of diet ME increased broiler performance, though no significant interactions could be found between energy and carnitine levels.
The present study was conducted to investigate the effects of the supplementation of an antibiotic growth promoter or novel feed additives with or without a xylanase-based enzyme complex to wheat-based diets on the growth performance, carcass yields and quality and intestinal characteristics (length of the total and small intestine, pH and viscosity of digesta, microflora) of Japanese quail. Eight hundred and forty day-old male quail chicks were randomly assigned to 14 groups of similar mean weight each of which included three replicates of 20 quail. The control group received a wheat-soyabean meal basal diet. In the treatment groups, the basal diet was supplemented with one of the following: an antibiotic, oregano essential oil, cinnamon essential oil, oregano essential oil plus cinnamon essential oil, a probiotic, a mannanoligosaccharide, and the same diets plus an enzyme. During the 35-d growth period there were no significant differences in body weight gain (BWG), feed intake (FI) or feed conversion ratio (FCR) of quail between dietary treatments. The use of oregano essential oil plus cinnamon essential oil or mannanoligosaccharide without the enzyme complex in the quail diets decreased plasma total cholesterol level compared to the control diet. The dietary supplementation of AGP, oregano essential oil, cinnamon essential oil, oregano essential oil plus cinnamon essential oil without the enzyme complex decreased plasma triglyceride levels compared with the control diet. When oregano essential oil, cinnamon essential oil, oregano oil plus cinnamon oil, a probiotic or a mannanoligosaccharide with an enzyme complex were used in a wheat based quail diet, the intestinal viscosity was significantly decreased compared to the control diet. Although the use of essential oils in combination with the enzyme complex, a probiotic and a mannanoligosaccharide with or without the enzyme complex in the wheat based diet significantly reduced the intestinal viscosity compared to the control diet, these treatments negatively decreased plasma total cholesterol and triglyceride.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.